Skip To Main Content
Arin Cox on Muck Rack

Arin Cox

As seen in: Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Arin Cox’s profile

Articles by Arin Cox

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM

|
By Nelson F. Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, Regan Murphy, Jacqueline Peng, Shridhar Parthasarathy, Sydney Dumont, Edward G Estrada, Meghan T. Logun, Yusha Sun, Xin Wang, Payal Grover, Jesse Rodriguez, Daniel Zhang, Kristen Park, Yao Fu, Nadine Ben Hamouda, Isaias Hernandez-Verdin, Lamia Lamrani, Kelly Hicks, Natalie Cooper, Christina Ekwegbara, Emma Bawden, Joshua J. Waterfall, Jaime Fuentealba, Marion Alcantara, John T Seykora, Stephen Prouty, David Barrett, esha banerjee, Arin Cox, Charles-Antoine Assenmacher, Camilla Macia, Melinda Yin, Erica Carpenter, Guo-li Ming, Catherine Sautès-Fridman, Wolf H. Fridman, Eric Tartour, E. John Wherry, Sebastian Amigorena, Joseph A Fraietta, MacLean P. Nasrallah, Hongjun Song, Tyler Miller, Stephen J. Bagley, Donald M. O’Rourke, Zev A. Binder, Cécile Alanio, Dana Silverbush
| Cell Press Verified
Keywords CAR T cell therapy glioblastoma longitudinal dynamics tumor microenvironment immunotherapy biomarkers immunology single-cell transcriptomics NK cells regulatory T cells myeloid immunosuppression Introduction Although chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies,1,2 translating this success to solid tumors has proven challenging.3,4 Key barriers include antigen paucity, inefficient T cell trafficking, tumor heterogeneity,...
Open in Who Shared Issue with article?

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM

|
By Nelson F. Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, Regan Murphy, Jacqueline Peng, Shridhar Parthasarathy, Sydney Dumont, Edward G Estrada, Meghan T. Logun, Yusha Sun, Xin Wang, Payal Grover, Jesse Rodriguez, Daniel Zhang, Kristen Park, Yao Fu, Isaias Hernandez-Verdin, Kelly Hicks, Natalie Cooper, Emma Bawden, Joshua J. Waterfall, Jaime Fuentealba, Marion Alcantara, John T Seykora, Stephen Prouty, David Barrett, esha banerjee, Charles-Antoine Assenmacher, Erica Carpenter, Guo-li Ming, Catherine Sautès-Fridman, Wolf H. Fridman, Eric Tartour, E. John Wherry, Sebastian Amigorena, Joseph A Fraietta, MacLean P. Nasrallah, Hongjun Song, Tyler Miller, Stephen J. Bagley, Donald M. O’Rourke, Zev A. Binder, Cécile Alanio, Dana Silverbush, Nadine Ben Hamouda, Lamia Lamrani, Christina Ekwegbara, Arin Cox, Camilla Macia, Melinda Yin
| Cell Press Verified
Keywords CAR T cell therapy glioblastoma longitudinal dynamics tumor microenvironment immunotherapy biomarkers immunology single-cell transcriptomics NK cells regulatory T cells myeloid immunosuppression Introduction Although chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies,1,2 translating this success to solid tumors has proven challenging.3,4 Key barriers include antigen paucity, inefficient T cell trafficking, tumor heterogeneity,...
Open in Who Shared Issue with article?
Show More